Effects of upregulated indoleamine 2, 3-dioxygenase 1 by interferon γ gene transfer on interferon γ-mediated antitumor activity

被引:0
|
作者
K Watcharanurak
L Zang
M Nishikawa
K Yoshinaga
Y Yamamoto
Y Takahashi
M Ando
K Saito
Y Watanabe
Y Takakura
机构
[1] Graduate School of Pharmaceutical Sciences,Department of Biopharmaceutics and Drug Metabolism
[2] Kyoto University,Department of Human Health Science
[3] Graduate School of Medicine and Faculty of Medicine,Department of Molecular Microbiology
[4] Kyoto University,undefined
[5] Graduate School of Pharmaceutical Sciences,undefined
[6] Kyoto University,undefined
来源
Gene Therapy | 2014年 / 21卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Interferon γ (IFN-γ), an anticancer agent, is a strong inducer of indoleamine 2,3-dioxygenase 1 (IDO1), which is a tryptophan-metabolizing enzyme involved in the induction of tumor immune tolerance. In this study, we investigated the IDO1 expression in organs after IFN-γ gene transfer to mice. IFN-γ gene transfer greatly increased the mRNA expression of IDO1 in many tissues with the highest in the liver. This upregulation was associated with reduced L-tryptophan levels and increased L-kynurenine levels in serum, indicating that IFN-γ gene transfer increased the IDO activity. Then, Lewis lung carcinoma (LLC) tumor-bearing wild-type and IDO1-knockout (IDO1 KO) mice were used to investigate the effects of IDO1 on the antitumor activity of IFN-γ. IFN-γ gene transfer significantly retarded the tumor growth in both strains without any significant difference in tumor size between the two groups. By contrast, the IDO1 activity was increased only in the wild-type mice by IFN-γ gene transfer, suggesting that cells other than LLC cells, such as tumor stromal cells, are the major contributors of IDO1 expression in LLC tumor. Taken together, these results imply that IFN-γ gene transfer mediated IDO1 upregulation in cells other than LLC cells has hardly any effect on the antitumor activity of IFN-γ.
引用
收藏
页码:794 / 801
页数:7
相关论文
共 50 条
  • [41] Indoleamine-2,3-dioxygenase and other interferon-γ-mediated pathways in patients with human immunodeficiency virus infection
    Schroecksnadel, Katharina
    Zangerle, R.
    Bellmann-Weiler, R.
    Garimorth, K.
    Weiss, G.
    Fuchs, Dietmer
    CURRENT DRUG METABOLISM, 2007, 8 (03) : 225 - 236
  • [42] THE SIGNAL-TRANSDUCTION MECHANISM RESPONSIBLE FOR GAMMA-INTERFERON-INDUCED INDOLEAMINE 2,3-DIOXYGENASE GENE-EXPRESSION
    KOIDE, Y
    YOSHIDA, A
    INFECTION AND IMMUNITY, 1994, 62 (03) : 948 - 955
  • [43] REGULATION OF INDOLEAMINE 2,3-DIOXYGENASE GENE-EXPRESSION IN HUMAN FIBROBLASTS BY INTERFERON-GAMMA - UPSTREAM CONTROL REGION DISCRIMINATES BETWEEN INTERFERON-GAMMA AND INTERFERON-ALPHA
    DAI, W
    GUPTA, SL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1990, 265 (32) : 19871 - 19877
  • [44] Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C
    A K Smith
    J S Simon
    E L Gustafson
    S Noviello
    J F Cubells
    M P Epstein
    D J Devlin
    P Qiu
    J K Albrecht
    C A Brass
    M S Sulkowski
    J G McHutchinson
    A H Miller
    Molecular Psychiatry, 2012, 17 : 781 - 789
  • [45] Indoleamine 2,3-dioxygenase mediates cell type-specific anti-measles virus activity of gamma interferon
    Obojes, K
    Andres, O
    Kim, KS
    Däubener, W
    Schneider-Schaulies, R
    JOURNAL OF VIROLOGY, 2005, 79 (12) : 7768 - 7776
  • [46] THE DEVELOPMENT OF ANTIBODY TO THE INTERFERON-INDUCED INDOLEAMINE 2,3-DIOXYGENASE AND THE STUDY OF THE REGULATION OF ITS SYNTHESIS
    RUBIN, BY
    ANDERSON, SL
    HELLERMANN, GR
    RICHARDSON, NK
    LUNN, RM
    VALINSKY, JE
    JOURNAL OF INTERFERON RESEARCH, 1988, 8 (05): : 691 - 702
  • [47] Promoter methylation regulates interferon-γ induced indoleamine 2,3-dioxygenase expression in breast cancer
    Noonepalle, Satish Kumar Reddy
    Lee, Eun Joon
    Ouzounova, Maria
    Kim, Jaejik
    Choi, Jeong-Hyeon
    Shull, Austin
    Pei, Lirong
    Kolhe, Ravindra
    Hsu, Pei-Yin
    Putluri, Nagireddy
    Huang, Tim Hui-Ming
    Sreekumar, Arun
    Korkaya, Hasan
    Munn, David
    Shi, Huidong
    CANCER RESEARCH, 2015, 75
  • [48] Indoleamine 2,3-dioxygenase (IDO) - The antagonist of type I interferon-driven skin inflammation?
    Scheler, Marina
    Wenzel, Joerg
    Tueting, Thomas
    Takikawa, Osamu
    Bieber, Thomas
    von Bubnoff, Dagmar
    AMERICAN JOURNAL OF PATHOLOGY, 2007, 171 (06): : 1936 - 1943
  • [49] CHARACTERIZATION OF AN INDOLEAMINE 2,3-DIOXYGENASE INDUCED BY GAMMA-INTERFERON IN CULTURED HUMAN-FIBROBLASTS
    PFEFFERKORN, ER
    REBHUN, S
    ECKEL, M
    JOURNAL OF INTERFERON RESEARCH, 1986, 6 (03): : 267 - 279
  • [50] Interferon-Gamma Induces Indoleamine 2,3-Dioxygenase and Causes Apoptosis in Lens Epithelial Cells
    Nagaraj, R. H.
    Mailankot, M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)